BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33762121)

  • 1. Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenografts.
    Marayati R; Bownes LV; Quinn CH; Wadhwani N; Williams AP; Markert HR; Atigadda V; Aye JM; Stewart JE; Yoon KJ; Beierle EA
    J Pediatr Surg; 2021 Jun; 56(6):1165-1173. PubMed ID: 33762121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts.
    Marayati R; Bownes LV; Stafman LL; Williams AP; Quinn CH; Atigadda V; Aye JM; Stewart JE; Yoon KJ; Beierle EA
    Transl Oncol; 2021 Jan; 14(1):100893. PubMed ID: 33010553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma.
    Marayati R; Williams AP; Bownes LV; Quinn CH; Stewart JE; Mroczek-Musulman E; Atigadda VR; Beierle EA
    J Pediatr Surg; 2020 Jun; 55(6):1072-1080. PubMed ID: 32164984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts.
    Williams AP; Garner EF; Stafman LL; Aye JM; Quinn CH; Marayati R; Stewart JE; Atigadda VR; Mroczek-Musulman E; Moore BP; Beierle EA; Friedman GK
    Transl Oncol; 2019 Oct; 12(10):1364-1374. PubMed ID: 31362265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.
    Garner EF; Stafman LL; Williams AP; Aye JM; Goolsby C; Atigadda VR; Moore BP; Nan L; Stewart JE; Hjelmeland AB; Friedman GK; Beierle EA
    J Neurooncol; 2018 Nov; 140(2):209-224. PubMed ID: 30132166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of PIM Kinases Promotes Neuroblastoma Cell Differentiation to a Neuronal Phenotype.
    Julson JR; Quinn CH; Bownes LV; Hutchins SC; Stewart JE; Aye J; Yoon KJ; Beierle EA
    J Pediatr Surg; 2023 Jun; 58(6):1155-1163. PubMed ID: 36907773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dauricine attenuates Oct4/sonic hedgehog co-activated stemness and induces reactive oxygen species-mediated mitochondrial apoptosis via AKT/β-catenin signaling in human neuroblastoma and glioblastoma stem-like cells.
    Liu C; Yang T; Cheng C; Huo J; Peng X; Zhang Y
    Phytother Res; 2024 Jan; 38(1):131-146. PubMed ID: 37821355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells.
    Naveen CR; Gaikwad S; Agrawal-Rajput R
    Phytomedicine; 2016 Jun; 23(7):736-44. PubMed ID: 27235712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts.
    Stafman LL; Williams AP; Marayati R; Aye JM; Markert HR; Garner EF; Quinn CH; Lallani SB; Stewart JE; Yoon KJ; Whelan K; Beierle EA
    Sci Rep; 2019 Sep; 9(1):13259. PubMed ID: 31519958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma.
    Liu CL; Chen YJ; Fan MH; Liao YJ; Mao TL
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor.
    Hämmerle B; Yañez Y; Palanca S; Cañete A; Burks DJ; Castel V; Font de Mora J
    PLoS One; 2013; 8(10):e76761. PubMed ID: 24116151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-fluorouracil suppresses stem cell-like properties by inhibiting p38 in pancreatic cancer cell line PANC-1.
    Zhao J; Shi X; Dong C; Liu R; Su L; Cao C
    Folia Histochem Cytobiol; 2022; 60(1):55-65. PubMed ID: 35103981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced differentiation inhibits sphere formation in neuroblastoma.
    Craig BT; Rellinger EJ; Alvarez AL; Dusek HL; Qiao J; Chung DH
    Biochem Biophys Res Commun; 2016 Aug; 477(2):255-9. PubMed ID: 27297102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.
    Pandian V; Ramraj S; Khan FH; Azim T; Aravindan N
    Stem Cell Res Ther; 2015 Feb; 6(1):2. PubMed ID: 25888913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of ascites derived exosomes on the stemness and invasion ability of ovarian cancer stem-like cell].
    Chen SP; Xia YF; Jiang HH; Sun WY; Lou YH
    Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):349-357. PubMed ID: 34034422
    [No Abstract]   [Full Text] [Related]  

  • 16. Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
    Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
    Mol Cancer Ther; 2015 Jul; 14(7):1559-69. PubMed ID: 25944918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
    Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
    World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation.
    Chen G; Wang Y; Zhao X; Xie XZ; Zhao JG; Deng T; Chen ZY; Chen HB; Tong YF; Yang Z; Ding XW; Guo PY; Yu HT; Wu LJ; Zhang SN; Zhu QD; Li JJ; Shan YF; Yu FX; Yu ZP; Xia JL
    J Exp Clin Cancer Res; 2021 Jun; 40(1):218. PubMed ID: 34193219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CFC1 is a cancer stemness-regulating factor in neuroblastoma.
    Chikaraishi K; Takenobu H; Sugino RP; Mukae K; Akter J; Haruta M; Kurosumi M; Endo TA; Koseki H; Shimojo N; Ohira M; Kamijo T
    Oncotarget; 2017 Jul; 8(28):45046-45059. PubMed ID: 28620148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.